These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6493832)

  • 21. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
    Comin CE; Saieva C; Messerini L
    Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malignant mesothelioma of the pleura. Morphometric study].
    Serio G; Caniglia DM; Pennella A; Giardina C; Dalena AM; Serio R; Lettini T; Ricco R
    Pathologica; 1997 Apr; 89(2):122-7. PubMed ID: 9411357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of immunohistochemistry in the differential diagnosis of serous effusions.
    Cangi MG; Pecciarini L; Doglioni C
    Adv Clin Path; 2000 Oct; 4(4):183-5. PubMed ID: 11436153
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathology of malignant mesothelioma.
    Van Marck E
    Lung Cancer; 2004 Aug; 45 Suppl 1():S35-6. PubMed ID: 15261431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen promotes adhesion of monocytic to human mesothelioma cells.
    Shetty S; Kumar A; Pueblitz S; Emri S; Gungen Y; Johnson AR; Idell S
    Thromb Haemost; 1996 May; 75(5):782-90. PubMed ID: 8725724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volume-regulated Cl- channels in human pleural mesothelioma cells.
    Meyer G; Rodighiero S; Guizzardi F; Bazzini C; Bottà G; Bertocchi C; Garavaglia L; Dossena S; Manfredi R; Sironi C; Catania A; Paulmichl M
    FEBS Lett; 2004 Feb; 559(1-3):45-50. PubMed ID: 14960305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al in Annals of Diagnostic Pathology 2007;11:297-311.
    Zheng W; Chambers SK
    Ann Diagn Pathol; 2008 Jun; 12(3):231-2; author reply 232-3. PubMed ID: 18486902
    [No Abstract]   [Full Text] [Related]  

  • 28. Papillary mesothelioma of the peritoneum in the absence of asbestos exposure.
    Meister T; Birkfellner T; Poremba C; Becker JC; Menzel J; Domschke W; Lerch MM
    Z Gastroenterol; 2003 Apr; 41(4):329-32. PubMed ID: 12695939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesothelial reaction in longstanding Crohn's ileitis simulating papillary mesothelioma.
    Wilkinson L; De P; Bloxham C
    J Clin Pathol; 2008 Oct; 61(10):1119-21. PubMed ID: 18820098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivity of integrin-linked kinase in human mesothelial cell proliferation.
    Watzka SB; Setinek U; Huber M; Cantonati H; Lax F; Watson S; Weigel G; Müller MR
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):107-10. PubMed ID: 18048409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precursor lesions of adenocarcinoma lung--two case reports.
    Jain D; Joshi K; Jindal SK
    Indian J Pathol Microbiol; 2005 Jul; 48(3):399-402. PubMed ID: 16761769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV; Nesland JM; Davidson B
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative lesions of the testis in ad libitum-fed and food-restricted Fischer-344 and FBNF1 rats.
    Thurman JD; Moeller RB; Turturro A
    Lab Anim Sci; 1995 Dec; 45(6):635-40. PubMed ID: 8746522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Precancerous changes in esophageal cancer].
    Lin PZ
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):391-5. PubMed ID: 6653366
    [No Abstract]   [Full Text] [Related]  

  • 36. [Differential diagnosis among reactive mesothelia, adenocarcinoma and malignant mesothelioma].
    Kamei T; Sakuma N
    Rinsho Byori; 1999 Jul; 47(7):601-13. PubMed ID: 10442038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic, cytogenetic, and molecular factors in mesothelial proliferations.
    Hicks J
    Ultrastruct Pathol; 2006; 30(1):19-30. PubMed ID: 16517467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
    Utermark T; Alekov A; Lerche H; Abramowski V; Giovannini M; Hanemann CO
    Cancer; 2003 Apr; 97(8):1955-62. PubMed ID: 12673723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin-like growth factors in lung precancer].
    Kogan EA; Orlova IA; Jack G
    Arkh Patol; 2001; 63(2):6-11. PubMed ID: 11392098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodular regenerative hyperplasia, dysplasia, and hepatocellular carcinoma.
    Wanless IR
    Am J Gastroenterol; 1996 May; 91(5):836-7. PubMed ID: 8633567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.